Regulation of liver enriched transcription factors in rat hepatocytes cultures on collagen and EHS sarcoma matrices

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Borlak, Jürgen ^a   Singh, Prafull Kumar ^a   Rittelmeyer, Ina ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AROCLOR 1254; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; COLLAGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3GAMMA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 6; LIVER ENRICHED TRANSCRIPTION FACTOR; MATRIGEL; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; AROCLOR; CYTOCHROME P450; DNA; DRUG COMBINATION; HEPATOCYTE NUCLEAR FACTOR 4; LAMININ; PROTEIN BINDING; PROTEOGLYCAN; TESTOSTERONE;

ALBUMIN SYNTHESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DNA BINDING; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; LIVER CELL; LIVER CELL CULTURE; LIVER METABOLISM; MALE; MARKER GENE; NONHUMAN; PROMOTER REGION; RAT; TESTOSTERONE METABOLISM; ANIMAL; CELL CULTURE; CELL SHAPE; DRUG COMBINATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; LIVER; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; SARCOMA; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

RATTUS;

ANIMALS; AROCLORS; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL SHAPE; CELLS, CULTURED; COLLAGEN; CYTOCHROME P-450 ENZYME SYSTEM; DNA; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTES; LAMININ; LIVER; MALE; PROTEIN BINDING; PROTEOGLYCANS; RATS, SPRAGUE-DAWLEY; SARCOMA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TESTOSTERONE; TRANSCRIPTION FACTORS;

EID: 84930660632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124867     Document Type: Article

References (61)

1. Hartung T, van Vliet E, Jaworska J, Bonilla L, Skinner N, Thomas R. Systems toxicology. ALTEX. 2012; 29: 119-128. PMID: 22562485
2. Luhe A, Suter L, Ruepp S, Singer T, Weiser T, Albertini S. Toxicogenomics in the pharmaceutical industry: Hollow promises or real benefit? Mutat Res. 2005; 575: 102-115. PMID: 15924886
3. Wang S, Nagrath D, Chen PC, Berthiaume F, Yarmush ML. Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng Part A. 2008; 14: 227-236. doi: 10.1089/tea.2007.0143 PMID: 18333775
4. Benton G, Kleinman HK, George J, Arnaoutova I. Multiple uses of basement membrane-like matrix (BME/matrigel) in vitro and in vivo with cancer cells. Int J Cancer. 2011; 128: 1751-1757. doi: 10.1002/ijc.25781 PMID: 21344372
5. LeBleu VS, Macdonald B, Kalluri R. Structure and function of basement membranes. Exp Biol Med (Maywood). 2007; 232: 1121-1129. PMID: 17895520
6. Borok Z, Hami A, Danto SI, Zabski SM, Crandall ED. Rat serum inhibits progression of alveolar epithelial cells toward the type I cell phenotype in vitro. Am J Respir Cell Mol Biol. 1995; 12: 50-55. PMID: 7811470
7. Harris AJ, Shaddock JG, Delongchamp R, Dragan Y, Casciano DA. Comparison of basal gene expression in cultured primary rat hepatocytes and freshly isolated rat hepatocytes. Toxicol Mech Methods. 2004; 14: 257-270. doi: 10.1080/15376520490434629 PMID: 20021105
8. Oda H, Nozawa K, Hitomi Y, Kakinuma A. Laminin-rich extracellular matrix maintains high level of hepatocyte nuclear factor 4 in rat hepatocyte culture. Biochem Biophys Res Commun. 1995; 212: 800-805. PMID: 7626113
9. Nguyen-Ngoc KV, Cheung KJ, Brenot A, Shamir ER, Gray RS, Hines WC, et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc Natl Acad Sci U S A. 2012; 109: E2595-604. PMID: 22923691
10. LeCluyse EL Witek RP, Andersen ME, Powers MJ. Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol. 2012; 42: 501-548. doi: 10.3109/10408444.2012.682115 PMID: 22582993
11. Ukairo O, Kanchagar C, Moore A, Shi J, Gaffney J, Aoyama S, et al. Long-term stability of primary rat hepatocytes in micropatterned cocultures. J Biochem Mol Toxicol. 2013; 27: 204-212. doi: 10.1002/jbt.21469 PMID: 23315828
12. Borlak J, Walles M, Elend M, Thum T, Preiss A, Levsen K. Verapamil: Identification of novel metabolites in cultures of primary human hepatocytes and human urine by LC-MS(n) and LC-NMR. Xenobiotica. 2003; 33: 655-676. PMID: 12851041
13. Soldatow VY, Lecluyse EL, Griffith LG, Rusyn I. In vitro models for liver toxicity testing. Toxicol Res (Camb). 2013; 2: 23-39. PMID: 23495363
14. Swift B, Pfeifer ND, Brouwer KL. Sandwich-cultured hepatocytes: An in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev. 2010; 42: 446-471. doi: 10.3109/03602530903491881 PMID: 20109035
15. Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol. 2013; 87: 1315-1530. doi: 10.1007/s00204-013-1078-5 PMID: 23974980
16. Hewitt NJ, Lechon MJ, Houston JB, Hallifax D, Brown HS, Maurel P, et al. Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev. 2007; 39: 159-234. PMID: 17364884
17. Caron JM. Induction of albumin gene transcription in hepatocytes by extracellular matrix proteins. Mol Cell Biol. 1990; 10: 1239-1243. PMID: 2406565
18. DiPersio CM, Jackson DA, Zaret KS. The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Mol Cell Biol. 1991; 11: 4405-4414. PMID: 1875930
19. Hayashi Y, Wang W, Ninomiya T, Nagano H, Ohta K, Itoh H. Liver enriched transcription factors and differentiation of hepatocellular carcinoma. Mol Pathol. 1999; 52: 19-24. PMID: 10439834
20. Sakai Y, Yamagami S, Nakazawa K. Comparative analysis of gene expression in rat liver tissue and monolayer- and spheroid-cultured hepatocytes. Cells Tissues Organs. 2010; 191: 281-288. doi: 10.1159/000272316 PMID: 20051666
21. Laurent T, Kataoka Y, Kobayashi S, Ando M, Nagamori S, Oda H. Spherical cell shape of FLC-4 cell, a human hepatoma cell, enhances hepatocyte-specific function and suppresses tumor phenotype through the integration of mRNA-microRNA interaction. Biol Open. 2012; 1: 958-964. doi: 10.1242/bio.20121438 PMID: 23213373
22. Bierwolf J, Lutgehetmann M, Feng K, Erbes J, Deichmann S, Toronyi E, et al. Primary rat hepatocyte culture on 3D nanofibrous polymer scaffolds for toxicology and pharmaceutical research. Biotechnol Bioeng. 2011; 108: 141-150. doi: 10.1002/bit.22924 PMID: 20824672
23. Tuschl G, Mueller SO. Effects of cell culture conditions on primary rat hepatocytes-cell morphology and differential gene expression. Toxicology. 2006; 218: 205-215. PMID: 16337326
24. Kheolamai P, Dickson AJ. Liver-enriched transcription factors are critical for the expression of hepatocyte marker genes in mES-derived hepatocyte-lineage cells. BMC Mol Biol. 2009; 10: 35. doi: 10.1186/1471-2199-10-35 PMID: 19389256
25. Elsdale T, Bard J. Collagen substrata for studies on cell behavior. J Cell Biol. 1972; 54: 626-637. PMID: 4339818
26. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150: 76-85. PMID: 3843705
27. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976; 13: 29-83. Review. PMID: 177845
28. Borlak J, Thum T. Induction of nuclear transcription factors, cytochrome P450 monooxygenases, and glutathione S-transferase alpha gene expression in Aroclor 1254-treated rat hepatocyte cultures. Biochem Pharmacol. 2001; 61: 145-153. PMID: 11163329
29. Borlak J, Hock A, Hansen T, Richter E. DNA adducts in cultures of polychlorinated biphenyl-treated human hepatocytes. Toxicol Appl Pharmacol. 2003; 188: 81-91. PMID: 12691726
30. Borlak J, Klutcka T. Expression of basolateral and canalicular transporters in rat liver and cultures of primary hepatocytes. Xenobiotica. 2004; 34: 935-947. PMID: 15801539
31. Thum T, Borlak J. Detection of early signals of hepatotoxicity by gene expression profiling studies with cultures of metabolically competent human hepatocytes. Arch Toxicol. 2008; 82: 89-101. PMID: 17851650
32. Anderson N, Borlak J. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev. 2008; 60: 311-357. doi: 10.1124/pr.108.00001 PMID: 18922966
33. Dunn JC, Yarmush ML, Koebe HG, Tompkins RG. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J. 1989; 3: 174-177. Erratum in: FASEB J. 1989; 3: 1873. PMID: 2914628
34. Niehof M, Borlak J. HNF4alpha dysfunction as a molecular rational for cyclosporine induced hypertension. PLoS One. 2011; 6:e16319. doi: 10.1371/journal.pone.0016319 PMID: 21298017
35. Niehof M, Borlak J. Expression of HNF4alpha in the human and rat choroid plexus: implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier. BMC Mol Biol. 2009; 10: 68. doi: 10.1186/1471-2199-10-68 PMID: 19575803
36. Niehof M, Borlak J. HNF4 alpha and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy. Diabetes. 2008; 57: 1069-1077. doi: 10.2337/db07-1065 PMID: 18184923
37. Kel AE, Niehof M, Matys V, Zemlin R, Borlak J. Genome wide prediction of HNF4alpha functional binding sites by the use of local and global sequence context.Genome Biol. 2008; 9: R36. doi: 10.1186/gb-2008-9-2-r36 PMID: 18291023
38. Niehof M, Borlak J. EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas. Gastroenterology. 2008; 134: 1191-1202. doi: 10.1053/j.gastro.2008.01.027 PMID: 18395097
39. Niehof M, Borlak J. RSK4 and PAK5 are novel candidate genes in diabetic rat kidney and brain. Mol Pharmacol. 2005; 67: 604-611. PMID: 15615695
40. Gorski K, Carneiro M, Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell. 1986; 47: 767-776. PMID: 3779841
41. Garaguso I, Borlak J. Matrix layer sample preparation: An improved MALDI-MS peptide analysis method for proteomic studies. Proteomics. 2008; 8: 2583-2595. doi: 10.1002/pmic.200701147 PMID: 18546159
42. Berthiaume F, Moghe PV, Toner M, Yarmush ML. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: Hepatocytes cultured in a sandwich configuration. FASEB J. 1996; 10: 1471-1484. PMID: 8940293
43. Shulman M, Nahmias Y. Long-term culture and coculture of primary rat and human hepatocytes. Methods Mol Biol. 2013; 945: 287-302. doi: 10.1007/978-1-62703-125-7-17 PMID: 23097113
44. Moghe PV, Berthiaume F, Ezzell RM, Toner M, Tompkins RG, Yarmush ML. Culture matrix configuration and composition in the maintenance of hepatocyte polarity and function. Biomaterials. 1996; 17: 373-385. PMID: 8745335
45. Borlak J, Blickwede M, Hansen T, Koch W, Walles M, Levsen K. Metabolism of verapamil in cultures of rat alveolar epithelial cells and pharmacokinetics after administration by intravenous and inhalation routes. Drug Metab Dispos. 2005; 33: 1108-1114. PMID: 15886350
46. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression? J Theor Biol. 1982; 99: 31-68. PMID: 6892044
47. Liu JK, DiPersio CM, Zaret KS. Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro. Mol Cell Biol. 1991; 11: 773-784. PMID: 1990282
48. Schrem H, Klempnauer J, Borlak J. Liver-enriched transcription factors in liver function and development. part I: The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev. 2002; 54: 129-158. PMID: 11870262
49. Schrem H, Klempnauer J, Borlak J. Liver-enriched transcription factors in liver function and development. part II: The C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol Rev. 2004; 56: 291-330.48. PMID: 15169930
50. Olsavsky KM, Page JL, Johnson MC, Zarbl H, Strom SC, Omiecinski CJ. Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol Appl Pharmacol. 2007; 222: 42-56. PMID: 17512962
51. Lazarevich NL, Shavochkina DA, Fleishman DI, Kustova IF, Morozova OV, Chuchuev ES, et al. Deregulation of hepatocyte nuclear factor 4 (HNF4) as a marker of epithelial tumors progression. Exp Oncol. 2010; 32: 167-171. PMID: 21403612
52. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, et al. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology. 2004; 39: 1038-1047. PMID: 15057908
53. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science. 2004; 303: 1378-1381. PMID: 14988562
54. Mitaka T. The current status of primary hepatocyte culture. Int J Exp Pathol. 1998; 79: 393-409. PMID: 10319020
55. Xu G, Yi S, Xu R. Effects of octreotide on implanted liver tumor after partial hepatectomy in rats. Zhonghua Wai Ke Za Zhi. 2001; 39: 948-950. PMID: 16201180
56. Santangelo L, Marchetti A, Cicchini C, Conigliaro A, Conti B, Mancone C, et al. The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4α. Hepatology. 2011; 53: 2063-2074. doi: 10.1002/hep.24280 PMID: 21384409
57. Nishiyori A, Tashiro H, Kimura A, Akagi K, Yamamura K, Mori M, et al. Determination of tissue specificity of the enhancer by combinatorial operation of tissue-enriched transcription factors. Both HNF-4 and C/EBP beta are required for liver-specific activity of the ornithine transcarbamylase enhancer. J Biol Chem. 1994; 269: 1323-1331. PMID: 8288597
58. Weltmeier F, Borlak J. A high resolution genome-wide scan of HNF4α recognition sites infers a regulatory gene network in colon cancer. PLoS One. 2011; 6: e21667. doi: 10.1371/journal.pone.0021667 PMID: 21829439
59. Iwahori T, Matsuura T, Maehashi H, Sugo K, Saito M, Hosokawa M, et al. CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver. Hepatology. 2003; 37: 665-673. PMID: 12601364
60. Meredith C, Scott MP, Renwick AB, Price RJ, Lake BG. Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices. Xenobiotica. 2003; 33: 511-527. PMID: 12746107
61. Xu C, Li CY, Kong AN. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res. 2005; 28: 249-268. PMID: 15832810